SCHEMBL1461003

SCHEMBL1461003

O=C(Cc1ccccc1)N(CC1CC1)C1CCC(C(O)(C(F)(F)F)C(F)(F)F)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.41
SLC6A4 P31645 4/20 0.41
HSD11B1 P28845 1/20 0.41
CTSD P07339 1/20 0.40
KCNH2 Q12809 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM3 P20309 1/20 0.39
LMNA P02545 1/20 0.39
MLYCD O95822 1/20 0.39
OPRM1 P35372 2/20 0.38
OPRD1 P41143 2/20 0.38
OPRK1 P41145 2/20 0.38
SLC6A3 Q01959 3/20 0.37
CCR5 P51681 2/20 0.37
CHRM4 P08173 1/20 0.37
CYP3A4 P08684 1/20 0.37
CHRM5 P08912 1/20 0.37
CYP2D6 P10635 1/20 0.37
CES1 P23141 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1459826 0.84 HSD11B1 (0.55) SLC6A2SLC6A4HSD11B1CHRM2CHRM3
SCHEMBL1459859 0.84 PTGDR2 (0.44) SLC6A2SLC6A4HSD11B1CHRM2CHRM3
SCHEMBL1460726 0.81 HSD11B1 (0.39) SLC6A2SLC6A4HSD11B1KCNH2MLYCD
SCHEMBL5355490 0.79 SLC6A2 (0.44) SLC6A2SLC6A4MLYCDOPRM1OPRD1
SCHEMBL1461928 0.78 OPRM1 (0.58) SLC6A2SLC6A4KCNH2LMNAOPRM1
SCHEMBL1460744 0.78 DPP4 (0.48) SLC6A2SLC6A4KCNH2CHRM2CHRM3
SCHEMBL1460765 0.78 AGER (0.43) CTSDCHRM2CHRM3OPRM1
SCHEMBL1460997 0.77 OPRM1 (0.55) KCNH2OPRM1CCR5MEN1KMT2A
SCHEMBL1460721 0.73 ESR2 (0.51) HSD11B1
SCHEMBL7601798 0.71 L3MBTL1 (0.64) CTSDLMNAOPRM1CCR5L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4644714-B2 2011-03-02 JP claimed
JP-2008524280-A 2008-07-10 JP claimed
EP-1831158-A1 NOVEL CYCLOHEXANE DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-09-12 EP claimed
US-7253282-B2 Hexafluoroisopropanol substituted cyclohexane derivatives HOFFMAN-LA ROCHE INC. (US) 2007-08-07 US claimed
WO-2006066779-A1 NOVEL CYCLOHEXANE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-06-29 WO claimed
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives HOFFMANN-LA ROCHE INC. 2006-06-22 US claimed
EP-1831158-A1 NOVEL CYCLOHEXANE DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-09-12 EP disclosed
US-7253282-B2 Hexafluoroisopropanol substituted cyclohexane derivatives HOFFMAN-LA ROCHE INC. (US) 2007-08-07 US disclosed
WO-2006066779-A1 NOVEL CYCLOHEXANE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-06-29 WO disclosed
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives HOFFMANN-LA ROCHE INC. 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives NR1H3, NR1H2, NR1I2 SLC6A2 3185/4885SLC6A4 2782/4885HSD11B1 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.